FDA Approved: OJEMDA — Original Application (Day One Biopharmaceuticals, Inc.)

View source ↗

Summary

FDA approved OJEMDA (tovorafenib) from Day One Biopharmaceuticals as a new drug for the treatment of patients with low-grade glioma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low-grade Glioma

Drugs mentioned

• OJEMDA (TOVORAFENIB)

Snippet

ORIG AP for OJEMDA (TOVORAFENIB)